Longitudinal Prediction of Individual Resilience and Difficulties in Coping with the COVID-19-Pandemic and its Consequences

Longitudinal Prediction of Individual Resilience and Difficulties in Coping with the COVID-19-Pandemic and its Consequences - ZF-IV-COVID-19

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00024616

Enrollment

360

Registered

2021-02-22

Start date

2021-02-25

Completion date

Unknown

Last updated

2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

development and stability of mental health problems (symptoms of depression and anxiety, and substance use) of young adults and their parents throughout the COVID-19 pandemic. development of life satisfaction of young adults and their parents throughout the COVID-19 pandemic

Interventions

Group 1: - 360 families with young adults aged 18 to 28 years (sample 1) and their parents aged 40 to 80 years (sample 2)

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Participation in the 18-years-katamnesis of the current DFG Project "Future Family IV - Longitudinal Prediction of Mental Health and Life Quality of Young Adults and Long-term Efficacy of a Universal Prevention Program" (Future Family IV; JO 1632/1-1). Within the Future Family IV project, we had to control for the effects of the COVID-19 pandemic, which is why detailed data on the pandemic was collected from August 2020. As a result, after the official recruitment start of the "ZF-IV-COVID-19" project on February 25, 2021, some young adults and their parents were retroactively included in the project at hand because the relevant data for the first assessment (T1) were already available.

Exclusion criteria

Exclusion criteria: no "informed consent" for participation in the additional research project

Design outcomes

Primary

Measure	Time frame
3 assessments (T1, T2, T3) 6 months apart. The data of the first assessment have already been collected since August 2020, but mostly since January 2021. The second assessment and thus the investigation of the development and stability of mental health problems during the pandemic and of the secondary outcome measures is planned to start on February 25, 2021. Assessment of the development and stability of mental health problems over a period of one year (self-report questionnaires at T1, T2, and T3): (1) depressive symptoms assessed by the German version of the depression scale of the Patient Health Questionnaire (PHQ-9; Kroenke et al., 2001); (2) anxiety symptoms assessed by the German version of the Generalized Anxiety Disorder Questionnaire (GAD-7; Spitzer et al., 2006); (3) positive mental health assessed by the Positive Mental Health Scale (PMH-Skala; Lutz et al. 1992; Lukat et al., 2016); (4) changes in the frequency of substance use (alcohol, nicotine, illegal drugs) throughout the pandemic (one item each, asking for the change in substance use since the beginning of the pandemic / the last assessment)	—

Measure

Time frame

3 assessments (T1, T2, T3) 6 months apart. The data of the first assessment have already been collected since August 2020, but mostly since January 2021. The second assessment and thus the investigation of the development and stability of mental health problems during the pandemic and of the secondary outcome measures is planned to start on February 25, 2021. Assessment of the development and stability of mental health problems over a period of one year (self-report questionnaires at T1, T2, and T3): (1) depressive symptoms assessed by the German version of the depression scale of the Patient Health Questionnaire (PHQ-9; Kroenke et al., 2001); (2) anxiety symptoms assessed by the German version of the Generalized Anxiety Disorder Questionnaire (GAD-7; Spitzer et al., 2006); (3) positive mental health assessed by the Positive Mental Health Scale (PMH-Skala; Lutz et al. 1992; Lukat et al., 2016); (4) changes in the frequency of substance use (alcohol, nicotine, illegal drugs) throughout the pandemic (one item each, asking for the change in substance use since the beginning of the pandemic / the last assessment)

—

Secondary

Measure	Time frame
Stability over a period of one year (self-report): (1) of the perceived negative impact of the pandemic / the current measures ordered by the authorities to slow down the pandemic; (2) of changes in relationship quality within the family; (3) of the current life satisfaction assessed by the "Fragebogen zur Lebenszufriedenheit" (FLZ; "Questionnaire about Life Satisfaction"; Henrich & Herschbach, 2000)	—

Measure

Time frame

Stability over a period of one year (self-report): (1) of the perceived negative impact of the pandemic / the current measures ordered by the authorities to slow down the pandemic; (2) of changes in relationship quality within the family; (3) of the current life satisfaction assessed by the "Fragebogen zur Lebenszufriedenheit" (FLZ; "Questionnaire about Life Satisfaction"; Henrich & Herschbach, 2000)

—

Countries

Germany

Contacts

Public ContactAnn-Katrin Job

Technische Universität Braunschweig Institut für Psychologie Abteilung für Klinische Psychologie, Psychotherapie und Diagnostik

a-k.job@tu-braunschweig.de00495313913605

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026